Clinical Trials

EU Panel Backs Darzalex for Early-Stage Multiple Myeloma
Management & Regulatory EU Panel Backs Darzalex for Early-Stage Multiple Myeloma

In the world of oncology, advancements in treatment options often mark pivotal moments in patient care. Ivan Kairatov, a biopharma expert with profound knowledge in tech and innovation, shares insights into the nuanced landscape of smouldering multiple myeloma (SMM) and its treatment. With his

How Are Imaging Breakthroughs Revolutionizing Cancer Treatment?
Tech & Innovation How Are Imaging Breakthroughs Revolutionizing Cancer Treatment?

In recent years, remarkable advancements in imaging technologies have dramatically transformed the landscape of cancer treatment and research. These imaging breakthroughs have enabled scientists and clinicians to analyze how cancer cells respond to various drugs simultaneously, marking a leap

Should Doctors Get Their Own Regulatory Body?
Management & Regulatory Should Doctors Get Their Own Regulatory Body?

Recent developments in the United Kingdom's medical regulatory sphere have stirred significant discourse among healthcare professionals, primarily focusing on the need for an exclusive regulatory framework for doctors. The British Medical Association (BMA) has been vocal about the necessity of

Long-Term Health Risks of Wildfire Smoke on Cardiorespiratory System
Research & Development Long-Term Health Risks of Wildfire Smoke on Cardiorespiratory System

Recent studies have illuminated critical insights into the long-term health risks associated with exposure to wildfire smoke, particularly its implications for the human cardiorespiratory system. As wildfires become more frequent and intense due to climate change, understanding these risks is

Can a New Vaccine Revolutionize Pancreatic Cancer Treatment?
Research & Development Can a New Vaccine Revolutionize Pancreatic Cancer Treatment?

In the rapidly advancing world of biopharmaceuticals, Ivan Kairatov stands as a beacon of knowledge. With his background in research and development and deep understanding of tech and innovation, Ivan has been pivotal in driving progress in the field. Today, he sheds light on new cancer vaccine

AI-Driven Drug Repurposing Offers New Hope for ALS Treatment
Tech & Innovation AI-Driven Drug Repurposing Offers New Hope for ALS Treatment

Amidst pressing challenges posed by amyotrophic lateral sclerosis (ALS), researchers are harnessing state-of-the-art AI methodologies to repurpose existing medications. ALS, widely recognized as Lou Gehrig's disease, is a relentless neurodegenerative disorder marked by the deterioration of motor

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later